Safety and efficacy of bilastine: a new H₁-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria

Author： Church Martin K

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.5, 2011-09, pp. : 779-793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bilastine: a guide to its use in the treatment of symptomatic allergic rhinoconjunctivitis and urticaria

By Lyseng-Williamson Katherine A. Carter Natalie A.

Drugs & Therapy Perspectives, Vol. 28, Iss. 11, 2012-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Bilastine: In Allergic Rhinitis and Urticaria

By Carter Natalie J.

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1257-1269

Adis International

Access to resources Recommend Favorite

Bilastine for the treatment of urticaria

By Jáuregui Ignacio

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1537-1544

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Ketotifen Eye Drops as Adjunctive Therapy to Mometasone Nasal Spray in Subjects with Seasonal Allergic Rhinoconjunctivitis

By Horak F.

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 597-604

Adis International

Access to resources Recommend Favorite

Preclinical Efficacy and Safety Pharmacology of SUN-1334H, a Potent Orally Active Antihistamine Agent

By Mandhane Sanjay N. Ayer Upendra B. Midha Ajay S. Chitturi Trinadha Rao Rajamannar Thennati

Drugs in R&D, Vol. 9, Iss. 2, 2008-01 ,pp. : 93-112

Adis International

Access to resources Recommend Favorite